Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

The effects of the prodrug Vyvanse on spatial working memory and adiposity in rats.

Ekstrand E, Murphy HM, Wideman CH.

Pharmacol Biochem Behav. 2019 Nov;186:172765. doi: 10.1016/j.pbb.2019.172765. Epub 2019 Aug 27.

PMID:
31470022
2.

Dissociable involvement of estrogen receptors in perirhinal cortex-mediated object-place memory in male rats.

Mitchnick KA, Mendell AL, Wideman CE, Jardine KH, Creighton SD, Muller AM, Choleris E, MacLusky NJ, Winters BD.

Psychoneuroendocrinology. 2019 Sep;107:98-108. doi: 10.1016/j.psyneuen.2019.05.005. Epub 2019 May 15.

PMID:
31125759
3.

Involvement of classical neurotransmitter systems in memory reconsolidation: Focus on destabilization.

Wideman CE, Jardine KH, Winters BD.

Neurobiol Learn Mem. 2018 Dec;156:68-79. doi: 10.1016/j.nlm.2018.11.001. Epub 2018 Nov 2. Review.

PMID:
30395938
4.

Conditioned aversive responses produced by delayed, but not immediate, exposure to cocaine and morphine in male Sprague-Dawley rats.

Guenther KG, Wideman CE, Rock EM, Limebeer CL, Parker LA.

Psychopharmacology (Berl). 2018 Nov;235(11):3315-3327. doi: 10.1007/s00213-018-5038-x. Epub 2018 Sep 24.

PMID:
30251163
5.

Development of novel tasks for studying view-invariant object recognition in rodents: Sensitivity to scopolamine.

Mitchnick KA, Wideman CE, Huff AE, Palmer D, McNaughton BL, Winters BD.

Behav Brain Res. 2018 May 15;344:48-56. doi: 10.1016/j.bbr.2018.01.030. Epub 2018 Feb 2.

PMID:
29412155
6.

Modafinil as a cognitive enhancer of spatial working memory in rats.

Murphy HM, Ekstrand D, Tarchick M, Wideman CH.

Physiol Behav. 2015 Apr 1;142:126-30. doi: 10.1016/j.physbeh.2015.02.003. Epub 2015 Feb 3.

PMID:
25656691
7.

An animal model of stress-induced cardiomyopathy utilizing the social defeat paradigm.

Wideman CH, Cierniak KH, Sweet WE, Moravec CS, Murphy HM.

Physiol Behav. 2013 Aug 15;120:220-7. doi: 10.1016/j.physbeh.2013.08.017. Epub 2013 Aug 17.

PMID:
23962681
8.

Zolpidem-induced changes in activity, metabolism, and anxiety in rats.

Murphy HM, Ihekoronze C, Wideman CH.

Pharmacol Biochem Behav. 2011 Mar;98(1):81-6. doi: 10.1016/j.pbb.2010.12.012. Epub 2010 Dec 20.

PMID:
21182854
9.

Constant light induces alterations in melatonin levels, food intake, feed efficiency, visceral adiposity, and circadian rhythms in rats.

Wideman CH, Murphy HM.

Nutr Neurosci. 2009 Oct;12(5):233-40. doi: 10.1179/147683009X423436.

PMID:
19761654
10.

Detection of myeloma in skeleton of mice by whole-body optical fluorescence imaging.

Oyajobi BO, Muñoz S, Kakonen R, Williams PJ, Gupta A, Wideman CL, Story B, Grubbs B, Armstrong A, Dougall WC, Garrett IR, Mundy GR.

Mol Cancer Ther. 2007 Jun;6(6):1701-8. Epub 2007 May 31.

11.

Analog to digital workflow improvement: a quantitative study.

Wideman C, Gallet J.

J Digit Imaging. 2006;19 Suppl 1:29-34.

12.

Implications of an animal model of sugar addiction, withdrawal and relapse for human health.

Wideman CH, Nadzam GR, Murphy HM.

Nutr Neurosci. 2005 Oct-Dec;8(5-6):269-76.

PMID:
16669597
13.

A laboratory animal model of human shift work.

Murphy HM, Wideman CH, Nadzam GR.

Integr Physiol Behav Sci. 2003 Oct-Dec;38(4):316-28.

PMID:
15119380
14.
15.

Cyclosporine A inhibits the adaptive responses to hypertonicity: a potential mechanism of nephrotoxicity.

Sheikh-Hamad D, Nadkarni V, Choi YJ, Truong LD, Wideman C, Hodjati R, Gabbay KH.

J Am Soc Nephrol. 2001 Dec;12(12):2732-41.

16.

Venous thrombosis in relation to fibrinogen and factor VII genes among African-Americans.

Austin H, Hooper WC, Lally C, Dilley A, Ellingsen D, Wideman C, Wenger NK, Rawlins P, Silva V, Evatt B.

J Clin Epidemiol. 2000 Oct;53(10):997-1001.

PMID:
11027931
17.

Vasopressin deficiency provides evidence for separate circadian oscillators of activity and temperature.

Wideman CH, Murphy HM, Nadzam GR.

Peptides. 2000 Jun;21(6):811-6.

PMID:
10959002
19.

Dominance of nonphotic cues in the circadian rhythm of body temperature in vasopressin-deficient rats.

Murphy HM, Nadzam GR, Schneider E, Smiley K, Wideman CH.

Ann N Y Acad Sci. 1999;897:436-9. No abstract available.

PMID:
10676472
20.

Cloning and expression of VEMA: a novel ventral midline antigen in the rat CNS.

Runko E, Wideman C, Kaprielian Z.

Mol Cell Neurosci. 1999 Dec;14(6):428-43.

PMID:
10656251
21.

Comparison of different methods of intracerebral administration of radioiododeoxyuridine for glioma therapy using a rat model.

Mairs RJ, Wideman CL, Angerson WJ, Whateley TL, Reza MS, Reeves JR, Robertson LM, Neshasteh-Riz A, Rampling R, Owens J, Allan D, Graham DI.

Br J Cancer. 2000 Jan;82(1):74-80.

22.

Interaction of Vasopressin and Splenda on Glucose Metabolism and Long-term Preferences under Ad-libitum and Food-restricted Conditions.

Murphy HM, Wideman CH, Cleary AM.

Nutr Neurosci. 1999;2(5):347-56. doi: 10.1080/1028415X.1999.11747289.

PMID:
27415807
23.

The role of vasopressin in modulating circadian rhythm responses to phase shifts.

Murphy HM, Wideman CH, Nadzam GR.

Peptides. 1998;19(7):1191-208.

PMID:
9786169
24.
25.

Vasopressin deficiency and phase advancement shifts in circadian rhythms with nocturnal or diurnal feeding.

Wideman CH, Murphy HM, Nadzam GR.

Ann N Y Acad Sci. 1997 Apr 24;814:287-91. No abstract available.

PMID:
9160979
26.

Identification of a novel Drosophila opsin reveals specific patterning of the R7 and R8 photoreceptor cells.

Chou WH, Hall KJ, Wilson DB, Wideman CL, Townson SM, Chadwell LV, Britt SG.

Neuron. 1996 Dec;17(6):1101-15.

27.

Interactions between vasopressin and food restriction on stress-induced analgesia.

Wideman CH, Murphy HM, McCartney SB.

Peptides. 1996;17(1):63-6.

PMID:
8822511
28.

The interaction of vasopressin and the photic oscillator in circadian rhythms.

Murphy HM, Wideman CH, Nadzam GR.

Peptides. 1996;17(3):467-75.

PMID:
8735974
29.

Vasopressin, immobilization, and the dexamethasone suppression test in rats.

Murphy HM, Wideman CH, Row JP.

Peptides. 1995;16(3):437-40.

PMID:
7651896
30.

Effects of glucose and food restriction on passive avoidance behavior in vasopressin-deficient rats.

Murphy HM, Babey EM, Wideman CH.

Ann N Y Acad Sci. 1994 Oct 31;739:328-9. No abstract available.

PMID:
7832487
31.

Vasopressin deficiency and blood glucose interactions on passive avoidance behavior.

Murphy HM, Babey EM, Wideman CH.

Peptides. 1994;15(8):1335-41.

PMID:
7700836
32.

Vasopressin deficiency and circadian rhythms during food-restriction stress.

Murphy HM, Wideman CH, Nadzam GR.

Peptides. 1993 Nov-Dec;14(6):1215-20.

PMID:
8134303
33.

Anticoagulant protein C pathway defective in majority of thrombophilic patients.

Griffin JH, Evatt B, Wideman C, Fernández JA.

Blood. 1993 Oct 1;82(7):1989-93.

PMID:
8400251
34.

The influence of vasopressin on heart rate during food-restriction stress.

Murphy HM, Wideman CH.

Ann N Y Acad Sci. 1993 Jul 22;689:643-4. No abstract available.

PMID:
8373066
35.

Protein S deficiency in men with long-term human immunodeficiency virus infection.

Stahl CP, Wideman CS, Spira TJ, Haff EC, Hixon GJ, Evatt BL.

Blood. 1993 Apr 1;81(7):1801-7.

PMID:
8461466
36.
37.

Vasopressin, corticosterone levels, and gastric ulcers during food-restriction stress.

Murphy HM, Wideman CH.

Peptides. 1992 Mar-Apr;13(2):373-6.

PMID:
1409015
38.

Vasopressin deficiency and the modulation of consummatory behavior.

Murphy HM, Wideman CH.

Peptides. 1991 Mar-Apr;12(2):319-22.

PMID:
2067983
39.

Effects of vasopressin replacement during food-restriction stress.

Wideman CH, Murphy HM.

Peptides. 1991 Mar-Apr;12(2):285-8.

PMID:
2067979
40.

Free protein S deficiency in a family with venous thrombosis.

Lauer CG, Reid TJ 3rd, Wideman CS, Evatt BL, Alving BM.

J Vasc Surg. 1990 Nov;12(5):541-4.

PMID:
2146406
41.

Multiple arteriovenous malformations of the small intestine in a patient with protein S deficiency.

Guarner J, Grossman B, Judd R, Wideman C, Evatt B.

Am J Clin Pathol. 1989 Sep;92(3):374-8.

PMID:
2528285
42.

Protein S and C antigen levels in proteinuric patients: dependence on type of glomerular pathology.

Allon M, Soffer O, Evatt BL, Hixon G, Wideman CS.

Am J Hematol. 1989 Jun;31(2):96-101.

PMID:
2525334
43.

Parent-to-child transplantation with cyclosporine immunosuppression.

Kahan BD, Conley S, Portman R, Lemaire R, Wideman C, Flechner S, Van Buren C.

J Pediatr. 1987 Dec;111(6 Pt 2):1012-6.

PMID:
3316572
44.

Risk factors for cadaveric donor allograft survival in cyclosporine-prednisone-treated recipients.

Kahan BD, Mickey R, Flechner SM, Lorber MI, Wideman CA, Kerman RH, Terasaki P, Van Buren CT.

Transplant Proc. 1987 Feb;19(1 Pt 3):1835-8. No abstract available.

PMID:
3547890
45.

Multivariate analysis of risk factors impacting on immediate and eventual cadaver allograft survival in cyclosporine-treated recipients.

Kahan BD, Mickey R, Flechner SM, Lorber MI, Wideman CA, Kerman RH, Terasaki P, Van Buren CT.

Transplantation. 1987 Jan;43(1):65-70.

PMID:
3541326
46.

Application of Bayesian forecasting to predict appropriate cyclosporine dosing regimens for renal allograft recipients.

Kahan BD, Kramer WG, Williams C, Wideman CA.

Transplant Proc. 1986 Dec;18(6 Suppl 5):200-3. No abstract available.

PMID:
3538571
47.

Analysis of pharmacokinetic profiles in 232 renal and 87 cardiac allograft recipients treated with cyclosporine.

Kahan BD, Kramer WG, Wideman CA, Frazier OH, Lorber MI, Williams C, Flechner SM, Cooley DA, Van Buren CT.

Transplant Proc. 1986 Dec;18(6 Suppl 5):115-9.

PMID:
3538563
48.

Comparison of five cyclosporine-prednisone regimens for induction of immunosuppression in cadaveric kidney recipients: a retrospective analysis of 245 cases.

Kahan BD, Lorber MI, Flechner SM, Van Buren CT, Jensen C, Wideman CA.

Transplant Proc. 1986 Apr;18(2 Suppl 1):59-65. No abstract available.

PMID:
3515696
49.

Demographic factors affecting the pharmacokinetics of cyclosporine estimated by radioimmunoassay.

Kahan BD, Kramer WG, Wideman C, Flechner SM, Lorber MI, Van Buren CT.

Transplantation. 1986 Apr;41(4):459-64.

PMID:
3515645
50.

Thrombin clotting activity measurement and standardization with lyophilized plasma.

Fenton JW 2nd, Wideman CS, Evatt BL.

Clin Chem. 1986 Feb;32(2):320-4.

Supplemental Content

Loading ...
Support Center